Healthcare -
Biotechnology - NASDAQ - US
$ 5.27
-0.189 %
$ 47 M
Market Cap
-20.27
P/E
ICCC - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ICCC - ImmuCell Corporation
1.75 M
LAST VALUE
-32.80%
2 YEAR CAGR
14.51%
5 YEAR CAGR
29.23%
10 YEAR CAGR